Mannas, Miles P.
Lee, Taeweon
Forbes, Connor M.
Hong, Tracey
Bisaillon, Andrea
Gleave, Martin E.
So, Alan I.
Mayson, Kelly
Black, Peter C. http://orcid.org/0000-0002-2919-7068
Article History
Received: 18 May 2019
Accepted: 17 August 2019
First Online: 27 August 2019
Compliance with ethical standards
:
: MP Mannas, T. Lee, CM Forbes, T. Hong, A. Bisaillon, and AI So declare that they have no conflict of interest. ME Gleave has the following disclosures: consultant for Abbvie, Astellas, Amgen, AstraZeneca, Bayer, GDx, Janssen, MDx, Pfizer, Sanofi; advisory boards for Astellas, Sanofi, Janssen, AstraZeneca, Bayer; honorarium from Astellas, Sanofi, Janssen, Bayer, Pfizer; research grants from Janssen, Astellas, Amgen; patents OGX-011, OGX-427; founder of OncoGenex Technologies. K Mayson is on a speaker’s board for 3 M Canada and advisory council for Edwards Lifesciences Canada. PC Black has the following disclosures: research grants from iProgen, GenomeDx, and Sitka; medical advisory boards for Abbvie, Astellas Pharma, Janssen Oncology, Amgen, Bayer, Merck, Sanofi Canada, Biosyent, Ferring, Roche Canada, MDxHealth, AstraZeneca and Urogen pharma.
: All data collection of this retrospective study is in accordance with the ethical standards and/or national health committee (UBC Clinical Research Ethics Board, H17-02508) and with the 1964 Helsinki declaration and its later amendments or comparable ethics standards. Due to the retrospective nature of the study, informed consent was not required by the clinical research ethics board.